Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial
Journal
The Lancet Oncology
Journal Volume
20
Journal Issue
12
Pages
1691-1701
Date Issued
2019
Author(s)
Shaw A.T.
Solomon B.J.
Chiari R.
Riely G.J.
Besse B.
Soo R.A.
Kao S.
Bauer T.M.
Clancy J.S.
Thurm H.
Martini J.-F.
Peltz G.
Abbattista A.
Li S.
Ou S.-H.I.
SDGs
Publisher
Lancet Publishing Group
Type
journal article